<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251108067920N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-02-06</date_registration>
      <primary_sponsor>University of Isfahan</primary_sponsor>
      <public_title>Studying the effect of two exercise training methods on controlling obesity symptoms in women</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of a Resistance Training Program on Lipid Profile and the Expression of miRNA-126 and miRNA-221 in Women with Overweight/Obesity</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-02-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87441</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: After obtaining the participants' consent and providing complete information about the intervention implementation process, 30 samples will be selected from among the eligible people.
There will be 30 volunteers in this study. In the second step, the numbers 1 to 30 are inserted on the paper and placed in the lottery container. The 15 people who chose even numbers from the lottery are in the resistance training group and the people who chose odd numbers are in the aerobic training group.
Blinding is not performed in this study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Obesity.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Participants in this group will engage in specific aerobic exercises at the gym for a duration of 8 weeks, attending 3 sessions each week. The exercises will be conducted at an intensity level of 70-80% of the maximum heart rate for a total of 90 minutes. The aerobic activities will consist of running in the gym for 60 minutes. During the initial four weeks, the exercises will be performed at an intensity of 60-70% of the maximum heart rate, structured into 4 sets of 10 minutes each, with 5 minutes allocated for active rest in between. From the fifth to the eighth week, the intensity will increase to 80-70% of the maximum heart rate, with 6 sets of 10 minutes each and 3 minutes of active rest. The exercises will be tailored according to the participants' age and gender. The intensity will be adjusted every 4 weeks based on the participants' progress. Each session will commence with a 15-minute warm-up and conclude with a 5-10 minute cool-down that includes stretching and flexibility exercises. Intervention 2: Intervention Group 2: Participants in this group will engage in resistance training at an intensity of 70-80% of their one repetition maximum, performing 3 sets of 10-12 repetitions using exercise machines for 90 minutes, three times a week over a period of 8 weeks. During the initial sessions, their one repetition maximum will be assessed across various movements, and the first four weeks will commence with an intensity of 70-75% of the one repetition maximum. In the subsequent four weeks, following a new one repetition maximum test, the training will progress to 75-80% of the one repetition maximum based on individual progress. The resistance training regimen will encompass: leg curl and extension exercises, squats, chest presses, and overhead pull-down exercises using the machine. Each session will start with a 15-minute warm-up and conclude with a cool-down period of 5-10 minutes that includes stretching and flexibility exercises.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The participants' data file will be accessible after obtaining permission from the university's Vice President for Research, and no decision has been made yet.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Roya Hamdiasl</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University St., University of Isfahan, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73441</zip>
        <telephone>+98 31 4525 5260</telephone>
        <email>royahmd221@gmail.com</email>
        <affiliation>The University of Isfahan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Vazgen Minasian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Isfahan, University St., Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73441</zip>
        <telephone>+98 31 3627 8066</telephone>
        <email>v.minasian@spr.ui.ac.ir</email>
        <affiliation>The University of Isfahan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Lack of participation in regular physical activity during the past year
Obesity (without other underlying diseases)
Being in the age range of 25-40 years
Having a body mass index of 26-35</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having cardiovascular diseases
Having musculoskeletal diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.09</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other obesity due to excess calories</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Participants in this group will engage in specific aerobic exercises at the gym for a duration of 8 weeks, attending 3 sessions each week. The exercises will be conducted at an intensity level of 70-80% of the maximum heart rate for a total of 90 minutes. The aerobic activities will consist of running in the gym for 60 minutes. During the initial four weeks, the exercises will be performed at an intensity of 60-70% of the maximum heart rate, structured into 4 sets of 10 minutes each, with 5 minutes allocated for active rest in between. From the fifth to the eighth week, the intensity will increase to 80-70% of the maximum heart rate, with 6 sets of 10 minutes each and 3 minutes of active rest. The exercises will be tailored according to the participants' age and gender. The intensity will be adjusted every 4 weeks based on the participants' progress. Each session will commence with a 15-minute warm-up and conclude with a 5-10 minute cool-down that includes stretching and flexibility exercises.</i_keyword>
      <i_keyword>Intervention Group 2: Participants in this group will engage in resistance training at an intensity of 70-80% of their one repetition maximum, performing 3 sets of 10-12 repetitions using exercise machines for 90 minutes, three times a week over a period of 8 weeks. During the initial sessions, their one repetition maximum will be assessed across various movements, and the first four weeks will commence with an intensity of 70-75% of the one repetition maximum. In the subsequent four weeks, following a new one repetition maximum test, the training will progress to 75-80% of the one repetition maximum based on individual progress. The resistance training regimen will encompass: leg curl and extension exercises, squats, chest presses, and overhead pull-down exercises using the machine. Each session will start with a 15-minute warm-up and conclude with a cool-down period of 5-10 minutes that includes stretching and flexibility exercises.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cholesterol. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: Measurements are performed using special kits and the ELISA method.</prim_outcome>
      <prim_outcome>MiRNA-221. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: This procedure is conducted utilizing specialized kits and a real-time PCR apparatus.</prim_outcome>
      <prim_outcome>MiRNA-126. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: This procedure is conducted utilizing specialized kits and a real-time PCR apparatus.</prim_outcome>
      <prim_outcome>Cardiorespiratory Endurance. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: The cardiorespiratory endurance of the participants is assessed through the Rockport Walking/Running Test.</prim_outcome>
      <prim_outcome>Body fat Percentage. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: The body fat percentage of participants will be assessed through the use of hand calipers, skinfold measurements taken from multiple regions, and the application of the Peterson equation.</prim_outcome>
      <prim_outcome>Triglycerides. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: Measurements are performed using special kits and the ELISA method.</prim_outcome>
      <prim_outcome>Low Density Lipoprotein-Cholesterol. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: Measurements are performed using special kits and the ELISA method.</prim_outcome>
      <prim_outcome>High Density Lipoprotein-Cholesterol. Timepoint: Before intervention and after 8 weeks of exercise interventions. Method of measurement: Measurements are performed using special kits and the ELISA method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Isfahan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-13</approval_date>
        <contact_name>University of Isfahan Research Ethics Committee</contact_name>
        <contact_address>University of Isfahan, University St.,  Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
